Literature DB >> 22483084

Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service.

Carina Bjartling1, Stellan Osser, Kenneth Persson.   

Abstract

OBJECTIVE: We sought to analyze the prevalence and clinical manifestations of Mycoplasma genitalium infection in a heterogeneous population of women. STUDY
DESIGN: The study was designed as a cross-sectional case-control study. Women attending a gynecological outpatient service from 2003 through 2008 were invited to participate.
RESULTS: The prevalence of M genitalium was 2.1% and of Chlamydia trachomatis was 2.8% among 5519 tested women. A total of 679 women were included. Both pelvic inflammatory disease (PID) and cervicitis were independently associated with M genitalium (odds ratio, 9.00; 95% confidence interval, 1.62-49.89 and odds ratio, 3.80; 95% confidence interval, 2.06-7.03, respectively). Women with C trachomatis had a higher frequency of both PID (18.3% vs 4.9%, P < .001) and cervicitis (33.4% vs 22.3%, P < .001) than women with M genitalium.
CONCLUSION: M genitalium was an independent and strong risk factor for both cervicitis and PID although, compared to C trachomatis, clinical manifestations were less frequent.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22483084     DOI: 10.1016/j.ajog.2012.02.036

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  24 in total

1.  Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.

Authors:  Kaitlin A Tagg; Neisha J Jeoffreys; Deborah L Couldwell; Jennifer A Donald; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

2.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

3.  Mycoplasma genitalium Infection in Kenyan and US Women.

Authors:  Jennifer E Balkus; Lisa E Manhart; Jørgen S Jensen; Omu Anzala; Joshua Kimani; Jane Schwebke; Juma Shafi; Charles Rivers; Emanuel Kabare; R Scott McClelland
Journal:  Sex Transm Dis       Date:  2018-08       Impact factor: 2.830

4.  Mycoplasma genitalium and preterm delivery at an urban community health center.

Authors:  Sarah H Averbach; Michele R Hacker; Timothy Yiu; Anna Merport Modest; Jordan Dimitrakoff; Hope A Ricciotti
Journal:  Int J Gynaecol Obstet       Date:  2013-07-05       Impact factor: 3.561

5.  RNA Biosignatures in Adolescent Patients in a Pediatric Emergency Department With Pelvic Inflammatory Disease.

Authors:  Fran Balamuth; Zhe Zhang; Eric Rappaport; Katie Hayes; Cynthia Mollen; Kathleen E Sullivan
Journal:  Pediatr Emerg Care       Date:  2015-07       Impact factor: 1.454

6.  Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents.

Authors:  Melinda A B Petrina; Lisa A Cosentino; Harold C Wiesenfeld; Toni Darville; Sharon L Hillier
Journal:  Anaerobe       Date:  2019-02-10       Impact factor: 3.331

7.  Risk factors for Mycoplasma genitalium endometritis and incident infection: a secondary data analysis of the T cell Response Against Chlamydia (TRAC) Study.

Authors:  Brandie D Taylor; Xiaojing Zheng; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; Toni Darville
Journal:  Sex Transm Infect       Date:  2018-03-21       Impact factor: 3.519

8.  Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey.

Authors:  Kirsten Salado-Rasmussen; Jørgen Skov Jensen
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

9.  A Silent Epidemic: The Prevalence, Incidence and Persistence of Mycoplasma genitalium Among Young, Asymptomatic High-Risk Women in the United States.

Authors:  Arlene C Seña; Jeannette Y Lee; Jane Schwebke; Susan S Philip; Harold C Wiesenfeld; Anne M Rompalo; Robert L Cook; Marcia M Hobbs
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

10.  Pelvic inflammatory disease: identifying research gaps--proceedings of a workshop sponsored by Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases, November 3-4, 2011.

Authors:  Toni Darville
Journal:  Sex Transm Dis       Date:  2013-10       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.